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Abstract.  Investigating the regulation of very late an- 
tigen (VLA)-mediated functions, we found that TS2/ 
16, a mAb directed against the/3 chain of the VLA 
group of integrins, can induce binding of resting pe- 
ripheral blood lymphocytes, cloned T lymphocytes, 
and Epstein Barr virus-transformed B cells to extra- 
cellular matrix components, fibronectin, laminin, and 
collagen, but not to fibrinogen. The antibody stimu- 
lates VLA-4-, VLA-5-, and VLA-6-mediated binding. 
Furthermore, it induces VLA-4-mediated binding to 
vascular cell adhesion molecule-1 expressed by rTNF- 
or-stimulated endothelial cells, but it does not stimu- 
late homotypic aggregation of cells as described for a 
number of anti-VLA-4~ antibodies (Bednarczyk, 
J.  L., and B.  W. McIntyre. 1990. J.  Immunol.  144: 
777-784;  Campanero, M.  R.,  R.  Pulido, M.  A. 
Ursa, M.  Rodrfguez-Moya, M.  O. de Landfizuri, and 
E  Sdnchez-Madrid. 1990. J.  Cell Biol.  110:2157- 
2165). Therefore, the stimulating activity of this anti-/~l 
antibody clearly contrasts with that of the anti-VLA-4ot 
antibodies, which induce homotypic cell aggregation, 
but not binding of cells to extracellular matrix compo- 
nents or endothelial cells, indicating that TS2/16  may 
generate different signals. 
The observation that also F(ab'): or Fab fragments 
of this anti-/~l  antibody stimulate binding to extracel- 
lular matrix components and endothelial ceils excludes 
the possibility that binding requires receptor crosslink- 
ing, or is Fc receptor mediated. Induction of this ad- 
hesion is cation and energy dependent and requires an 
intact cytoskeleton. Although changes in the confor- 
mation of VLA integrins induced by this antibody may 
regulate their functional activity, the dependence on 
metabolic energy indicates that intracellular processes 
may also play a role. 
T 
HE very late antigens (VLAs) t are expressed on both 
hematopoietic and nonhematopoietic ceils and form 
the/~ 1 group of the integrin superfarnily of adhesion 
receptors (Hynes, 1987). Other groups of this still expand- 
ing family comprise the /~2, or leukocyte integrin group 
(Sanchez-Madrid  et al., 1983), and thb/$3 group, which con- 
sists of the platelet antigen IIb/IIIa (Phillips et al., 1988) and 
the vitronectin receptor (Pytela et al.,  1985). The VLA 
molecules mediate adhesion of cells with components of the 
extracellular matrix (ECM) (Hemler, 1990). Recently, it has 
been observed that VLA-4 is also able to interact with glyco- 
proteins expressed at the surface of various types of ceils in- 
cluding endothelium. One of these ligands has been identi- 
fied as the vascular cellular adhesion molecule-1 (VCAM-1) 
(Elices et al.,  1990; Taichman et al.,  1991). 
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1. Abbreviations  used in this paper: Coil, collagen type I; EBV, Epstein Barr 
virus; ECM, extracellular  matrix;  FG, fibrinogen;  FN, fibronectin;  HE, 
hydroethidine;  LAD,  leukocyte  adhesion  deficiency;  LFA-1, lymphocyte 
function-associated  antigen-l;  LM, laminin;  PBL, peripheral  blood lym- 
phocyte;  TNE  tumor necrosis  factor;  VCAM-1, vascular  cell adhesion 
molecule-l;  VLA, very late activation antigen. 
High affinity interaction of integrins with their respective 
ligands, requires activation of the integrin receptor. This has 
now been demonstrated for the/31 (Shimizu et al., 1990),/32 
(Van Kooyk et al., 1989; Dustin and Springer, 1989), and 133 
(O'Toole et al., 1990) group of this adhesion receptor family. 
Phorbol esters,  such as PMA, are able to induce a high 
affinity state of the/31, 152, and 133 integrins (Patarroyo et al., 
1985; Phillips et al., 1988; Shimizu,  1990; Springer, 1990; 
Wilkins et al., 1991). In addition, a number of more physio- 
logical stimulatory pathways have been recognized to stimu- 
late integrin-mediated  adhesion. Among others, signals me- 
diated through CD2  and CD3,  which are expressed  by T 
lymphocytes, can stimulate  B1- and 132- mediated interac- 
tions (Dustin and Springer,  1989; Van Kooyk et al.,  1989; 
Nojima et al., 1990), and thrombin is able to induce adhe- 
sion of platelets, through IIb/IIIa, a 83 integrin (Ginsberg et 
al.,  1980). 
We previously showed that an antibody directed against a 
unique epitope located on the ot chain of lymphocyte func- 
tion-associated antigen-1 (LFA-1), is capable of inducing a 
high affinity state of LFA-1, a 132 integrin. Similarly, specific 
antibodies have been recognized that stimulate/33-mediated 
functions (Gulino et al., 1990). Recently, Campanero et al. 
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certain  antibodies directed against VLA-4  o~  subunit are 
capable  of inducing homotypic aggregation of leukocytes 
suggesting that antibodies against VLA-4 can also induce a 
high affinity state of this receptor. 
In the present study, we demonstrate that an anti-B1 anti- 
body is also capable of inducing a high affinity state of VLA-4 
and stimulates VLA-4-mediated adhesion. In addition we 
show that several other VLA antigens that comprise the E1 
family can also be stimulated. Interestingly, a clear distinc- 
tion  can  be  made  between  the  VLA-mediated functions 
stimulated by anti-VLAot antibodies and those stimulated by 
the anti-~l antibody used in this study. 
Materials and Methods 
Cell Lines and Cell Culture 
Peripheral blood lymphocytes (PBLs) were isolated from mononuclear cells 
by centrifugal elutriation as described previously (Figdor et al., 1984).  The 
human Tetanus toxoid specific T helper clone HY 827 was described by 
Yssel et al. (1986);  the cytotoxic, alloreactive T cell clone JS 136, directed 
against an HLA-DRw6 determinant by Borst et al. (1986).  The LFA-1 nega- 
tive T cell clones, LAD 4, LAD 6.1, and LAD 6.6, were raised by limiting 
dilution of peripheral blood lymphocytes of a patient (VA) with leukocyte 
adhesion deficiency (LAD) lacking mRNA expression for the CD18 protein 
(Van Kooyk et al.,  1989).  T cell clones, KZ 21.1 and KZ 25.7 were estab- 
lished from LFA-1 positive lymphocytes. The B cell lines were established 
by Epstein Barr virus (EBV) transfection of B cells from patient VA and B 
cells from donor JS. Cloned T cells were cultured in Iscove's medium sup- 
plemented with 5 % human serum and stimulated weekly with irradiated 
allogeneic peripheral blood mononucleax cells (PBMCs) and EBV-trans- 
formed B cells (JY), 0.2/~g/ml phytohaemagglutinin, and 100 U/ml rIL-2, 
kindly provided by Eurocetus (Amsterdam, The Netherlands). EBV-trans- 
formed B cells were maintained in Iscove's medium containing 10% FCS. 
Antibodies 
The  following VLAa mAbs were used.  HP1/2  and HP1/3  (anti-VLA-4, 
CIM9d), (Campanero et al., 1990); B-5G10 (anti-VLA-4, CD49d) (Hemier 
et al., 1987); SAM-1 (anti-VLA-5,  CIM9e) (Keizer et al., 1987); and GoH3 
(anti-VLA-6,  CD49f)  (Sonnenberg et al.,  1988)  are directed against 
subunits of the VLAs. The antibodies TS2/16  and A-1A5 (Hemler et al., 
1984),  K20 (Amiot et al., 1988), and AIIB2 (Hall et al., 1989) are directed 
against  the  BI  subunit  of the  integrins  (CD29).  CLB-LFA-1/1  (CD18) 
(Miedema et al.,  1984),  C17  (CD41)  (Tetteroo et al.,  1983),  and 439.9B 
(CD61)  (Falconi et al., 1988) are reactive with other B subonits of the inte- 
grins. The antibodies 32.2 and IV.3 are directed against Fc~RI (CD64) and 
FcTRII (CD32) (Anderson et al., 1986),  respectively, and antibody CLB- 
Fc3,R gran  1 against Pe-tRIII (CD16)  (Klaassen et al.,  1990).  mAb 4B9 
recognizes VCAM-1 (Schwartz et al.,  1990) and W6/32, which is used as 
control antibody reacts with MHC class I (Barnstable et al.,  1978). 
Fab and F(alY)2 fragments of TS2/16 were generated by papain and pep- 
sin digestion as described by Mather et al. (1987)  and checked for purity 
with an Fc-specific ELISA and by SDS-PAGE, followed by Coomassie blue 
staining. SDS-PAGE was carded out on vertical slab gels (5-15%) accord- 
ing to a modification of the Laemmli procedure (Laemmli,  1970). 
Cell Binding to ECM Components 
For cell attachment to ECM, flat bottom 96-well microtiter plates (Costar, 
Cambridge, MA) were coated with 100/zl of 20/~g/ml fibronectin (FN), 
20 /zg/ml  laminin (LM),  40  /~g/ml collagen type I  (Coll),  or 40 /~g/ml 
fibrinogen (FG), (Sigma Chemical Co., St. Louis, MO), for 16 h at 4°C, 
washed, and subsequently incubated with 1% wt/vol BSA for 1 h by 37°C. 
T  cell clones and EBV-transformed B  cells were labeled with 51Cr for 
1.5-2 h, washed, and resuspended in Iscove's medium containing 0.25% 
wt/vol BSA. 1 x  104 radiolabeled cells were plated in triplicate (50/.d final 
volume), centrifuged for 1 rain at 1,000 rpm and incubated for 30 rain at 
37°C and 5%  CO2.  Unbound cells were removed by washing with PBS 
supplemented with 0.25%  wt/vol BSA,  1 mM Mg  2+,  and  1 mM Ca  2+. 
Bound cells were lysed by detergent and the radioactivity of the lysate was 
counted in a gamma counter. Results were expressed as the mean percentage 
of cell binding from triplicate wells. For induction or enhancement of bind- 
ing to ECM, 2  x  105 cells/ml were preincubated with 10/zg/ml purified 
TS2/16,  or 50 nM PMA for 10 min. For antibody inhibition, 25/~1  with 
1:100 dilution or 10 t~g/ml purified mAb was added to 25/zl cell suspension 
and preincubated for 20 rain at 4°C. Sodium azide (2% wt/vol) and deoxy- 
glucose (50 raM, SERVA, Heidelberg, FRG) were added to inhibit cell me- 
tabolism. Stanrosporin (200 nM; Kyowa Hakko, Europe GMBH, Diissel- 
dorf, FRG) was added to inhibit protein kinase C activity.  Involvement of 
cytoskeleton was determined by adding Cytochalasin B  (20/zM;  Sigma 
Chemical Co.).  Cation dependence was determined by preincubation of 
cells with 5 mM EDTA or 5 mM EGTA for 30 rain at 37°C. 
Cross-Competitive mAb Cell Binding Assay 
For cross-competitive  mAb cell binding assays, ceils were preincubated (30 
rain, 0°C) with different dilutions of unlabeled mAb in Iscove's medium 
containing 0.25% wt/vol BSA. Then, purified TS2/16 mAb (10/zg/ml) la- 
beled with 125I (Amersham International, Amersham, UK), as described 
by Greenwood et al. (1963),  was added and incubated for another 30 min 
on ice.  Unbound radioactivity was removed by washing four times and 
bound labeled antibody was counted in a gamma counter and expressed as 
the mean cpm of triplicate tests. 
lmmunofluorescence 
Cells were incubated (30 min, 0°C)  in PBS containing  1%  wt/vol BSA 
(Sigma Chemical Co.), and 0.02%  wt/vol sodium azide, with appropriate 
dilutions of the different mAb, followed by incubation with FITC-labeled 
goat F(ab')2 anti-mouse IgG antibody (GAM-FITC; Nordic, Tilburg, The 
Netherlands) or by FITC-labeled mouse anti-rat kappa antibody (MARK- 
FITC,  Sanbio, Uden, The Netherlands) for 30 min at 0°C.  The relative 
fluorescence intensity was measured on a  FACScan (Becton Dickinson, 
Mountain View, CA). 
Binding of CeUs to Endothelium 
Endothelial cells (2  x  105 cells/ml), isolated from human umbilical cord 
veins and cultured two or three passages as described by Te Velde et al. 
(1987),  were grown in 100/~1 RPMI/well containing 10%  human serum, 
in FN-coated (2/~g/100/~1), flat bottom 96-well plates (Costar, Cambridge, 
MA). After 2 d of culturing, the cells were stimulated, for 24 h, with 100 
U/ml rTNF-u (supcrnatant of cDNA-transfected COS cells). Before initia- 
tion of  the adhesion experiment the wells with endothelial cells were washed 
with RPMI.  T  cells were labeled with 51Cr for  1.5-2  h,  washed,  and 
resuspended in Iscove's medium with 0.25% wt/vol BSA. 1 x  104 radiola- 
beled T cells were plated in triplicate (100/zl final volume), and incubated 
for 30 min at 37°C and 5% CO2. Unbound cells were removed by washing 
with PBS supplied with 0.25% wt/vol BSA, 1 mM Mg  2+, and 1 mM Ca  2+. 
Bound cells were lysed by detergent and the radioactivity of the cell lysate 
was counted in a gamma counter. Results were expressed as the mean per- 
centage of cell binding from triplicate wells. For induction or enhancement 
of binding to ECM, cells were preincubated with 1:100 ascites dilution of 
mAb or 10 #g/ml purified "17S2/16 for 30 min at 4oc. For antibody inhibition 
studies, cells were preincubated (30 min, 4°C) with 1:100 ascites dilution 
or 10/~g/ml purified mAb. 
Quantitative Aggregation Assay 
Homotypic aggregation was quantitatively determined by double fluores- 
cence (Kuljpers et al., 1990).  Cells (2  x  106 cells/ml in Iscove's medium) 
were stained with the red dye Hydroethidine (HE; Polyscience, Inc., War- 
rington, PA; 40 mg/ml in N,N-dimethylacetonide) at concentrations of 3 
ng/ml, or with the green dye sulfofluorescein diacetate (SFDA; Molecular 
Probes, Junction City, OR) at a concentration of 5/zg/ml. After 1 h of incu- 
bation at 37°C, cells were washed twice with Iscove's medium with 10% 
FCS. Cells were seeded in round bottom wells (5  ×  104 HE labeled and 
5  x  104 SFDA labeled cells) in 100 ~1. After 2 h of incubation at room 
temperature,  cells were fixed with 0.5%  wt/vol paraformaldehyde, and 
aggregation was counted in a  FACScan.  Double-colored aggregates were 
calculated as a percentage of the total HE colored events counted from 
duplicate wells. 
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Induction of  [31-mediated Adhesion of T and 
B Lymphocytes to ECM 
LFA-1 positive (JS 136) and LFA-1 negative (LAD 6.1) cloned 
T  cells and  LFA-1 positive (JS  EBV)  and  LFA-1  negative 
(LAD EBV) EBV-transformed B cells were studied with re- 
spect to VLA-mediated binding to ECM. Table I shows that 
the cloned T  cells hardly bind to FN, LM, Coil type I, or 
Table L Induction of T and B Cell Adhesion to 
ECM Components 
Adhesion* 
Treated with  BSA  FN  LM  Coil(1)  FG 
%  %  %  %  % 
Medium  JS  136  <*  <  <  <  < 
LAD 6.1  <  <  <  <  < 
JS EBV  <  10  <  <  < 
LAD EBV  <  9  <  <  < 
PMA  JS  136  <  37  8  12  < 
LAD 6.1  <  19  18  26  < 
JS EBV  <  22  <  <  < 
LAD EBV  <  19  <  <  < 
TS2/16  JS  136  <  36  14  17  < 
anti-VLA-/3  LAD 6.1  <  31  28  31  < 
JS EBV  <  43  <  <  < 
LAD EBV  <  37  <  <  < 
A-1A5  JS 136  <  19  <  <  < 
anti-VLA-/~  LAD 6.1  <  11  <  <  < 
JS EBV  <  25  <  <  < 
LAD EBV  <  19  <  <  < 
AIIB2  JS 136  <  <  <  <  < 
anti-VLA-~  LAD 6.1  <  <  <  <  < 
JS EBV  <  <  <  <  < 
LAD EBV  <  <  <  <  < 
K20  JS 136  <  <  <  <  < 
anti-VLA-~  LAD 6.1  <  <  <  <  < 
JS EBV  <  14  <  <  < 
LAD EBV  <  11  <  <  < 
HP 1/3  JS 136  <  <  <  <  < 
anti-VLA-4  LAD 6.1  <  <  <  <  < 
JS EBV  <  14  <  <  < 
LAD EBV  <  12  <  <  < 
HP  1/2  JS  136  <  <  <  <  < 
anti-VLA-4  LAD 6.1  <  <  <  <  < 
JS EBV  <  <  <  <  < 
LAD EBV  <  <  <  <  < 
B-5G10  JS  136  <  <  <  <  < 
anti-VLA-4  LAD 6.1  <  <  <  <  < 
JS EBV  <  12  <  <  < 
LAD EBV  <  11  <  <  < 
SAM-1  JS 136  <  <  <  <  < 
anti-VLA-5  LAD 6.1  <  <  <  <  < 
JS EBV  <  12  <  <  < 
LAD EBV  <  13  <  <  < 
*  SD <3% 
* <  = <5% adhesion. 
FG, while the EBV transformed B  cells showed significant 
binding to FN.  We observed that, TS2/16,  an anti-~  anti- 
body, stimulated adhesion to FN, LM, and Coil but not to 
FG (Table I). To extend this observation, we tested a  large 
panel of anti-/~l and anti-VLA-4 antibodies, as well as.a num- 
ber of antibodies directed against other/3 integrin subunits, 
for their capacity to induce binding of cloned T cells or EBV- 
transformed B  cells to ECM  (Table I).  None of the other 
anti-/3 or anti-u antibodies induced strong ECM binding, ex- 
cept mAb A-1A5, which stimulated moderate binding of lym- 
phocytes to  FN.  Furthermore,  antibodies directed against 
other anti-/3 integrin subunits did not induce ECM binding 
(not shown), which is not surprising since expression of  these 
integrins is low or absent on these T  and B cells (Table II). 
Treatment with the phorbol ester PMA also stimulated bind- 
ing of both T cell clones and EBV-transformed B cells to FN, 
had a  moderate effect on cloned T  cell binding to LM and 
Coil, but did not stimulate binding of B cells to LM and Coil 
(Table I). 
From these results we conclude that TS2/16 has a unique 
property to induce T  and B  cell binding to FN, and T  cell 
binding to LM and Coil type I. 
To exclude that the TS2/16 induction of adhesion to FN 
was restricted to the two T cell clones and B cell lines used, 
we tested a  number of T  cell clones and B  cell lines with 
comparable expression of integrin molecules on the cell sur- 
face. Furthermore, resting lymphocytes were tested on their 
capacity to bind to ECM after induction with TS2/16.  Only 
a low number of resting PBLs spontaneously adhered to FN 
and LM  (17  and  8%,  respectively). After incubation with 
TS2/16 adhesion of PBL to FN and LM was enhanced to 39 
and 35 %, respectively. No significant binding was observed 
to Coil I and FG after TS2/16 inducement (data not shown). 
Table III shows that for all T cell clones, B cells, and resting 
PBL tested, adhesion to FN was induced by TS2/16 and in- 
hibited by mAb HP1/2,  an anti-VLA-4 antibody, and not by 
mAb against/32. 
Intact Anti-[31 Antibodies, but also F(ab')2 and Fab 
Fragments Induce/31-mediated Adhesion 
To  determine  whether  TS2/16-induced  adhesion  required 
receptor crosslinking, or depended on the Fc part of the mol- 
ecule, we prepared F(ab')2 and Fab fragments. The purity of 
the preparations was checked with an Fc-specific ELISA (de- 
tection level t> 0.001%  intact IgG) and by SDS-PAGE under 
nonreducing conditions (Fig.  1 A). Both assays showed no 
detectable level of IgG. The results in Fig.  1 B  show that 
F(ab')2 and Fab fragments are as effective in inducing bind- 
ing of cloned T  ceils to FN as intact IgG. 
These results demonstrate that crosslinking of VLA mole- 
cules is not required to induce adhesion, and that the Fc por- 
tion of IgG plays no role. Moreover, the T  cells used in this 
study are Fc receptor negative (Table II). 
Anti-:31-stimulated Adhesion Is Mediated by 
Different VLA Molecules 
The results shown in Table I suggest that TS2/16 stimulates 
binding through various VLA integrins, because adhesion 
was induced to FN, LM, and Coll. We performed blocking 
studies with different anti-ct antibodies to determine which 
adhesion molecules mediated induced adhesion by TS2/16 
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mAb  Antigen  HY 827 
Relative fluorescence intensity 
LAD 6.1  JS EBV  LAD EBV  PBL 
GAM FITC  Control  4 
MARK FITC  Control  4 
CLB-10G11  VLA-2  10 
J143  VLA-3  12 
HP  1/2  VLA-4  152 
HP1/3  VLA-4  145 
B-5G10  VLA-4  136 
SAM- 1  VLA-5  7 
GoH3*  VLA-6  8 
TS2/16  ~1  75 
A-1A5  ~1  73 
AIIB2*  ~1  70 
K20  ~1  61 
CLB-LFA-1/1  /~2  81 
C17  ~3  4 
439.9B  /34  5 
Control mAb 
4B9  VCAM-1  5 
32.2  Fc3,RI  6 
IV.3  FcTRII  4 
CLB-Fe~R granl  FcTRIII  3 
4  5  4  3 
3  4  3  5 
10  6  5  4 
13  13  10  3 
128  67  92  20 
128  63  88  19 
113  58  84  16 
7  8  6  6 
7  5  4  25 
68  55  59  41 
68  60  58  37 
80  45  66  51 
50  57  47  46 
6  21  5  23 
4  6  5  6 
5  5  5  4 
4  5  5  4 
5  5  4  3 
5  5  7  4 
4  5  4  3 
* Rat antibody. 
Fab  fragments.  The  results  in  Fig.  2  show  that  TS2/16- 
induced binding  of cloned T  cells  to FN was completely 
mediated by VLA-4 and VLA-5, whereas binding of resting 
PBL to FN  was  only partially  dependent  on VLA-4 and 
VLA-5 (Fig. 2, A and C).  Furthermore,  binding to LM of 
cloned T cells after TS2/16 induction, was partially mediated 
by VLA-6, whereas  binding of resting  PBL seemed to be 
completely dependent on VLA-6 (Fig. 2, B and D), appar- 
ently due to the high expression of VLA-6 and the absence 
of VLA-3 on resting  PBL  (Table  II).  Inhibition of PMA- 
induced adhesion to ECM showed similar results (Fig. 2). 
mAb against/32,/33,  or ~  integrins did not affect TS2/16- 
Table III. Lymphocyte  Adhesion to FN  after Induction 
with TS2/16 
Adhesion (%)* 
TS2/16 induced 
Without  mAb HP1/2  mAb CLB-LFA1/1 
activation  (anti-VLA-4)  (anti-if2) 
T cell clones 
LAD 4  14  38  10  39 
LAD 6.1  4  29  6  31 
LAD 6.6  9  29  12  29 
JS  136  3  19  7  17 
HY 827  14  44  18  46 
KZ 25.7  3  18  8  21 
B cell lines 
JY EBV  12  25  4  22 
JS EBV  15  32  5  34 
LAD EBV  9  25  2  26 
Resting PBL  17  39  21  37 
*  SD  <3%. 
induced cell adhesion (not shown). No differences were ob- 
tained between LFA-1 positive and LFA-1 negative T and B 
cells (not shown). 
From these data we conclude that TS2/16 induces T  and 
B cell adhesion to ECM by activation of various VLA inte- 
grins. 
Blocking of TS2/16 Stimulated Adhesion by 
Pretreatment with Other Anti-J31 Antibodies 
We  repeatedly  found that  other  anti-~l  antibodies,  AIIB2 
and K20, were not capable of inducing adhesion,  and that 
A-1A5 induced only moderate binding to FN (Table I). These 
three  anti-~  antibodies  could  not  inhibit  TS2/16-induced 
adhesion when added simultaneously or after TS2/16 to the 
cells (not shown). Therefore, we tested their capacity to pre- 
vent TS2/16-induced adhesion by incubating the cells with 
the  antibodies  before  addition  of TS2/16.  The  antibodies 
AIIB2 and A-1A5, but not K20, prevented induction of adhe- 
sion of cloned T cells (Fig. 3 A) and EBV-transformed B cells 
(not  shown)  by TS2/16,  indicating  that  AIIB2 and  A-1A5 
recognize an epitope close to that of TS2/16. Crossblocking 
experiments (Fig. 3 B) confirmed that AIIB2 and A-IA5 in- 
deed  prevented  binding  of 12~I-labeled  TS2/16.  Consistent 
with reports in the literature  (Hemler et al.,  1984; Hall et 
al., 1989), incubation of the cells with AIIB2, but not A-1A5, 
inhibited  spontaneous adhesion to ECM (Fig.  3 A). 
From  these  data  we  conclude that  TS2/16,  A-1A5,  and 
AIIB2 recognize closely located epitopes on the/31 subunit. 
However, these antibodies have entirely different effects on 
VLA-mediated adhesion. 
Anti-~  l- and PMA-induced Adhesion Have Similar 
Kinetics Characteristic for Integrin Molecules 
Fig. 4 shows that TS2/16-induced adhesion of cloned T cells 
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PAGE under nonreducing con- 
ditions  of  10  #g  of TS2/16 
IgG1 (lane 1),  10 #g TS2/16 
F(ab')2  fragments  (lane  2), 
and  10 #g  TS2/16 Fab  flag- 
ments (lane 3).  (B) Compar- 
ison  of purified  TS2/16 IgG 
(--o-),  TS2/16 F(ab')2  (--o-), 
and  TS2/16 Fab  fragments 
(-l-) in their capacity  to in- 
duce binding of cloned T cells 
HY 827 to FN. One represen- 
tative experiment out of  two is 
shown. 
to FN,  LM, and Coil occurred more rapidly compared to 
adhesion induced by PMA. In addition, a higher percentage 
of the ceils adhered to LM and Coil after incubation with 
TS2/16 in comparison with PMA. Adhesion is initiated after 
5 min of incubation with TS2/16 and a maximum of adhesion 
is reached after 40 min. LFA-1 positive and LFA-1 negative 
T  cell clones showed the same kinetics (not shown). 
Furthermore, we observed that TS2/16- and PMA-induced 
adhesion is cation and temperature dependent, and requires 
an intact cytoskeleton, since EDTA, incubation at 0°C, and 
cytochalasin B completely inhibited adhesion of LFA-1 nega- 
tive cloned T cell to FN (Fig. 5) LM and Coil (not shown). 
Induction of adhesion by TS2/16 or PMA could not be in- 
hibited by deoxyglucose or sodium azide, but a combination 
Figure  2.  Inhibition  of cell 
binding to FN and LM. Cells 
were  stimulated  with  TS2/16 
(am) or PMA (~) for l0 rain. 
Subsequently  adhesion  was 
followed for 30 min with  an 
inhibitory  antibody  as  indi- 
cated. Binding of LFAol nega- 
tive cloned T cells to FN (A), 
and LM (B), and resting PBL 
to FN (C), and LM (D). One 
representative experiment out 
of three is shown. 
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Figure 3. (A) Effects of other/~1  antibodies on TS2/16 induced bind- 
ing to ECM of T cell clone HY 827. T cells were pretreated with 
AIIB2, A-1A5, K20, and CLB-LFA1/I as control, for 10 min, before 
activation with TS2/16.  Adhesion to BSA (t2),  FN (i),  LM (m), 
and Coil ([]) was measured after 30 min at 37°C.  One representa- 
tive experiment out  of two  is  shown.  (B)  Cross-competition of 
antS-El mAb. Cells were incubated with unlabeled mAb, before the 
incubation  with  10/zg/ml  125I-labeled TS2/16.  Unlabeled TS2/16 
(1 mg/ml --o--), A-1A5 (ascites --m-), AIIB2 (ascites -¢-), K20 (1 
mg/ml --o-), and  HPI/3  (ascites --z~-) were used  in a  dilution  of 
1:100-1:100,000. 
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Figure 4.  Kinetics of TS2/16  and PMA induced binding to ECM 
to: (A) FN, (B) LM, (C) Coil type I. HY 827 cells stimulated with 
PMA (-o--), or TS2/16  (-i-),  or without stimulation (-o-). 
of both components completely blocked adhesion  (Fig.  5), 
suggesting that active cell metabolism is important.  Stauro- 
sporin, a protein kinase C inhibitor,  inhibited PMA-induced 
adhesion  (Fig.  5  B) but had  no effect, or only a  moderate 
effect on TS2/16-induced  adhesion  (Fig.  5  A).  Using these 
agents to inhibit "IS 2/16 and PMA-induced  LFA-1 positive 
T  and  B  cell  adhesion  to  FN  showed  similar  results  (not 
shown). 
We conclude  from these data that TS2/16-induced  adhe- 
sion is characteristic  for integrin molecules, and that it may 
require  intact  signalling  functions  of the T  and  B  cells. 
Anti-t31 Induces Adhesion to Endothelial Cells 
Since TS2/16  antibodies  induce VLA-4-mediated  adhesion 
to  ECM  we  investigated  the  capacity  of this  antibody  to 
stimulate  VLA-4-mediated  binding  of cloned  T  and  EBV- 
transformed B  lymphocytes to endothelium.  We and others 
(Schwartz et al.,  1990; Vennegoor et al.,  1992) showed that 
binding  of lymphocytes  to  endothelium  was  mediated  by 
LFA-1/ICAM-1  or -2 and the VLA-4/VCAM-1  interactions. 
Figure 5.  Effect of temperature, depletion of cation, cytochalasin 
B, sodium azide, deoxyglucose and stanrosporin on T cell binding 
to FN. (n) control cells (without activation). (a) T cell clone LAD 
6.1 after activation with (A) TS2/16 and (B) PMA. One representa- 
tive experiment out of four is shown. 
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activated cultured human endothelial cells. Adhesion was measured 
after treatment of (A) LAD 6.1 (LFA-I negative) and (B) JS 136 
(LFA-1 positive) cells with medium (n),  TS2/16 (m) and HP1/3 
(m). Anti-VLA-4, anti-VCAM-1 and anti-LFA-1 antibodies were 
tested on their capacity to inhibit adhesion. One representative ex- 
periment out of five is shown. 
VLA-4-mediated adhesion depended on the expression of 
VCAM-1,  which  was  best  visualized with LFA-1 negative 
(LAD) cells and after treatment of the endothelial cells with 
cytokines like rTNF-o~ (Fig. 6 A). TS2/16 was capable to en- 
hance  binding  to  cloned  LAD  T  lymphocytes to  rTNF- 
a-treated (24 h), VCAM-1 positive endothelial cells (Fig. 6 
A) but not to untreated endothelium (not shown). TS2/16 en- 
hancement of adhesion to rTNF-ot-stimulated endothelium 
of LFA-1 positive cells (JS  136) was hardly possible since 
these cells utilize primarily the LFA-1/ICAM  pathway (Fig. 
6 B). Both anti-VCAM-1 and anti-VLA-4 antibodies inhibited 
TS2/16-induced adhesion of LFA-1 negative cloned T  lym- 
phocytes, demonstrating that TS2/16 specifically stimulated 
the VLA-4/VCAM-1 adhesion pathway (Fig. 6 A), whereas 
LFA-1 positive cloned T  cells (Fig. 6 B) were inhibited by 
antibodies against the LFA-1/3 chain. However, after induc- 
tion with TS2/16 the inhibitory capacity of the LFA-1 mAb 
decreased, suggesting a more dominant role for the VLA- 
4/VCAM-1  adhesion route (Fig.  6 B).  Pretreatment of the 
cells  with  mAb  AIIB2,  a  distinct  anti-ill  antibody,  com- 
pletely  abrogated  TS2/16-induced  adhesion  (not  shown), 
comparable to the TS2/16-induced adhesion to ECM (Fig. 
3  A),  confirming  that  the  epitope  recognized by  AIIB2 
prevented binding of TS2/16. 
From these results we conclude that El-induced adhesion 
via VLA-4 implicates both adhesion to FN and to VCAM-1. 
TS2/16 Does Not Stimulate Homotypic 
Cell Aggregation 
None of the anti-VLA t~ subunit antibodies used in this study 
were capable of inducing adhesion to ECM or endothelial 
cells (Table I, Fig. 6). Recently it has been reported that cer- 
tain anti-VLA-4 antibodies were capable of inducing adhe- 
sion (Campanero et al.,  1990; Bednarczyk and McIntyre, 
1990). These observations were confirmed by the results in 
Fig. 7, which show that mAb HP1/3 directed against VLA-4 
induced homotypic aggregation of both LFA-1 positive and 
LFA-1 negative cloned T cells and EBV-transformed B cells. 
In contrast, we never observed homotypic aggregation in- 
Figure 7. Homotypic aggrega- 
tion  of LFA-1 positive  (JS), 
and  LFA-1  negative (LAD) 
cloned T and EBV transformed 
B cells. Cells were stimulated 
with  medium,  HP1/3 (anti- 
VLA-4), TS2/16  (anti-/31), and 
PMA. Antibodies HP1/2, (m, 
anti-VLA-4), CLB-LFA-Ifl  (~I, 
anti-t2) and W6/32 (n, con- 
trol mAb) were tested on their 
capacity to inhibit adhesion. 
One representative experiment 
out of four is shown. 
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by anti-VLA-4 antibody (HP1/2) and not by mAb against ~2 
(CLB-LFA-1/1),  demonstrating  the  specificity  of  the  re- 
sponse. Furthermore, PMA readily induced cell aggregation 
of LFA-1 positive cells, which could be inhibited by anti-/32 
antibody,  but  hardly  by  blocking  anti-VLA-4  antibody 
(HP1/2). 
These results indicate that TS2/16 and the stimulating anti- 
VLA-4a antibodies (Campanero et al.,  1990; Bednarczyk 
and McIntyre, 1990) may distinctly regulate VLA-mediated 
adhesion. PMA mimics the effects induced by both anti-or or 
-/3 antibodies. 
Discussion 
High affinity interactions  of integrins  with their respective 
ligands require activation of the integrin receptor. This has 
now been demonstrated for the ~  (Nojima et al.,  1990),/32 
(Van Kooyk et al., 1989; Dustin and Springer,  1989), and/33 
(O'Toole et al., 1990) group of this adhesion receptor family. 
PMA has been recognized to induce/32-mediated adhesion 
(Patarroyo et al., 1985; Springer,  1990),/33-mediated adhe- 
sion  (Phillips  et  al.,  1988),  and  more  recently  also  /31- 
mediated adhesion (Shimizu et al.,  1990). 
We have previously observed that ~2-mediated adhesion 
can be induced by an antibody, termed NKI-L16, (Keizer et 
al.,  1988)  directed  against  a  Ca2+-dependent  epitope  lo- 
cated on the c~ subunit of LFAd  (Van Kooyk et al.,  1991). 
The antibody induces homotypic lymphocyte aggregation, 
as well as binding  to purified ICAM-1  (Van Kooyk et al., 
1991). In addition, the antibody enhances LFA-l-dependent 
adhesion to endothelium (our unpublished results).  As ex- 
pected, expression of the epitope recognized by TS2/16 is not 
dependent on the presence of divalent cations (not shown), 
since the cation binding domains are located on the ot subunit 
of integrins. In this respect, TS2/16 contrasts with NKI-L16 
or antibody 24, both of which recognize ct subunits of the 
/32 group of integrins  (Dransfield and Hogg, 1989). Never- 
theless, a striking parallel exists between the earlier observa- 
tions with NKI-L16 and those reported with TS2/16 in this 
paper (a) Both antibodies induce adhesion to their respective 
ligands. (b) Induction of adhesion is not dependent on the Fc 
portion of the antibody. (c) Stimulation of adhesion is also 
not dependent on receptor crosslinking, since Fab fragments 
of both antibodies are as effective as IgG. (d) The kinetics 
of the induced adhesion by both antibodies parallels that of 
PMA. (e) Induction of adhesion requires an intact cytoskele- 
ton and the presence of divalent cations, all characteristics 
of integrin-mediated interactions. (f) The induction of VLA- 
mediated cell adhesion by TS2/16 is dependent on metabolic 
energy,  since a  combination  of deoxyglucose and  sodium 
azide prevents induction of adhesion.  We have previously 
reported that induction of LFA-l-mediated cell adhesion is 
not affected by sodium azide (Van Kooyk et al., 1991). Simi- 
larly deoxyglucose alone does not affect adhesion (our un- 
published results). However, a more detailed analysis shows 
that a combination of azide and deoxyglucose is inhibitory 
(our unpublished  results),  similar to what we observe for 
TS2/16. 
One explanation for the capacity of these antibodies to in- 
duce cell adhesion is that they affect the tertiary structure of 
integrins,  and that they induce a  high  affinity state of the 
receptor by conformational  changes.  Gulino et al.  (1990) 
elegantly demonstrated that this can indeed be the case. They 
have shown that a high affinity state of IIb/~la can be induced 
by anti-IIb antibodies in isolated IIb/Ula molecules bound to 
a cell-free substrate (Gulino et al.,  1990). These results also 
demonstrate that high avidity interactions can be obtained in 
the absence of associated molecules, for instance, cytoskele- 
tal elements. Induction of 131- (this study) and t$2- (Van Kooyk 
et al.,  1991) mediated interactions by the antibodies TS2/16 
and NKI-L16, respectively, may also involve conformational 
changes, but their dependence on metabolic activity of the 
cell suggests that intraceUular processes play a role. At pres- 
ent it is not known which steps in the adhesion process are 
affected by these inhibitors of cell metabolism. It is tempting 
to speculate that direct conformational changes induced by 
these antibodies affect intracellular changes, for example the 
association  of the  intracellular  domains  of these  integrin 
molecules with the cytoskeletal elements, and that these lat- 
ter interactions are disturbed by metabolic inhibitors.  This 
hypothesis is supported by the observation that induction of 
a high affinity state of LFA-1 induced by CD2 and CD3 trig- 
gering, or PMA is completely abrogated by the protein ki- 
nase inhibitor staurosporin or by azide alone, whereas this 
does not affect NKI-L16-induced  adhesion  (Van Kooyk et 
al.,  1991).  Similarly,  staurosporin  inhibits  PMA-induced 
adhesion (Fig.  5) but not TS2/16-induced adhesion via/31. 
TS2/16 specifically induces binding to different ligands of 
VLA integrins used in this study, including extracellular ma- 
trix components (FN, LM, Coil type I) and cell surface mol- 
ecules (VCAM-1).  It is of interest to note that, on cloned T 
cells but not on EBV-transformed B cells, expression of the 
subunit of VLA-4 is much higher than that of the/31 subunit 
(Table II), suggesting a possible association of the VLA c~ 
subunit with a/3 subunit on cloned T cells other than the ones 
we have tested.  Furthermore,  it is noteworthy that binding 
to LM can be readily induced despite the low expression of 
VLA-6 on the T cell clones used in this study. In addition, 
the mAb blocking studies indicate that binding of cloned T 
cells to LM is not exclusively mediated by VLA-6, suggest- 
ing  that  other  LM receptors  (VLA-2 and  VLA-3) are  in- 
volved. In contrast,  binding of resting PBL to LM is com- 
pletely VLA-6 dependent, according to the high expression 
of VLA-6. Binding to FN implicated both the so called CS-1 
site (Wayner et al.,  1989) and the RGD site (Ruoslahti and 
Pierschbacher,  1987) since both VLA-4- and VLA-5-medi- 
ated FN binding has been observed, respectively. This sug- 
gests that the activity of TS2/16 is not restricted to certain 
VLA molecules but probably involves all members of this 
integrin group.  In addition,  the results emphasize a major 
role for the fll  subunit in the regulation of VLA-mediated 
adhesion.  Similarly,  anti-~3  antibodies have been demon- 
strated  to  stimulate  /33-mediated  adhesion  (Kouns  et al., 
1990). This function is however not restricted to anti-/3 anti- 
bodies, since stimulatory anti-a  antibodies have also been 
described (Gulino et al.,  1990). 
A clear distinction can be made between the stimulatory 
activities of certain antibodies against the VLA-4ot subunit 
and the anti-B1 antibody used in this study. Previous reports 
show that anti-VLA-4ot antibodies can induce homotypic cell 
aggregation  (Campanero  et  al.,  1990;  Bednarczyk  and 
MacIntyre, 1990). Our present observations are in line with 
these  studies  and  indicate  that  anti-VLA-4ct  antibodies 
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duce binding to isolated ECM components or to VCAM-1, 
as measured by binding to rTNF-ot-stimulated endothelium. 
Similar observations have been made in a study  in which a 
large panel of anti-VLA-4ot antibodies has been tested (Pu- 
lido  et  al.,  1991).  In contrast  to  these  anti-a  antibodies, 
TS2/16 does not induce homotypic aggregation but stimu- 
lates all other VLA-mediated interactions tested so far. Fur- 
thermore, the study of Neugebauer et al. (1991) indicates that 
various VLA-mediated functions can be distinctly regulated 
through  the ~1 subunit.  They have observed that an anti-/S1 
antibody inhibits adhesion to vitronectin but at the same time 
stimulates adhesion to LM and Coll. From these results two 
conclusions may be drawn: (a) VLA-mediated functions can 
be differentially regulated at the cell surface, depending on 
the epitope that is triggered;  and (b) VLA-mediated homo- 
typic cell aggregation may require other signals than interac- 
tions of VLA molecules with ECM or VCAM-1.  This latter 
conclusion  is  supported  by  the  observation  that  VLA- 
4-mediated  homotypic  adhesion  is  not  mediated  through 
VCAM-1  (Pulido et al.,  1991).  Moreover, the T and B cells 
used in this study  do not express VCAM-1  (Table III). 
Only a limited number of antibodies is capable of stimulat- 
ing VLA integrin-mediated  functions.  Merely anti-c~ anti- 
bodies directed against  certain  epitopes  of VLA-4  induce 
aggregation (Pulido et al., 1991),  whereas of all the antibod- 
ies tested in this study, TS2/16 is the only anti-/5"l antibody 
capable of inducing strong binding of cloned T lymphocytes 
and EBV-transformed  B lymphocytes to ECM and VCAM-1. 
This observation suggests that TS2/16 recognizes a unique 
epitope on the/~1 subunit despite the fact that other antibod- 
ies, A-1A5 and AI1B2, have been allocated to the same or a 
closely related site (Fig. 3 B; Hemler et al.,  1984).  Cross- 
blocking and adhesion inhibition studies (Fig. 3) suggest that 
A-1A5, AIIB2, and TS2/16 recognize partially  overlapping, 
but functionally different epitopes. The differences observed 
between  cloned  T  and EBV-transformed  B  cells  in VLA- 
mediated adhesion can be due to variable cleavage of the a-4 
molecule (Hemler et al., 1990), or to differences in glycosy- 
lation, which can directly alter the binding properties of anti- 
bodies to VLA-4.  Similar to these findings, induction of/~ 2 
or/$3 integrin-mediated adhesion is also limited to antibod- 
ies  directed  against  specific  epitopes  (Van  Kooyk  et  al., 
1991;  Gulino  et  al.,  1990;  Kouns  et  al.,  1990).  Little  is 
known about the intracellular events stimulated by TS2/16 or 
by the stimulating anti-VLA4ct antibodies that induce aggre- 
gation. The functional data suggest different signalling path- 
ways depending on the epitope against which the antibody 
is directed.  So far we can not dissect differences in signal 
transduction. PMA, which stimulates both homotypic adhe- 
sion and binding to ECM or VCAM-1 and thus behaves like 
a stimulating anti-VLA-4ct  and anti-/~ antibody,  is sensitive 
to PKC  inhibitors,  whereas TS2/16-stimulated  adhesion is 
insensitive. These findings suggest that two or three distinct 
intracellular events  may be operative  in VLA-4-mediated 
adhesion.  Additional evidence supporting the concept that 
intracellular  signals  are  generated  by  VLA  integrins  and 
regulate leukocyte functions, comes from observations that 
VLA-ligand interactions alone, or in conjunction with anti- 
CD3  antibodies,  stimulate serine esterase release by cyto- 
toxic  T  cells,  T  lymphocyte  proliferation,  and  cytokine 
production by T helper cells or hybridoma cells (Davis et al., 
1990;  Nojima et al.,  1990;  Yamada et al.,  1991).  Alterna- 
tively, binding of antibodies against  VLA-4 or 131 may dis- 
tinctly  affect the tertiary structure of the molecules, thus, 
resulting in different  binding properties of VLA-4. 
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